Early development of metabolic syndrome in patients subjected to lung transplantation

Gabriele Savioli, Sara Surbone, Ilaria Giovi, Francesco Salinaro, Paola Preti, Federica Meloni, Tiberio Oggionni, Stefano Perlini

Research output: Contribution to journalArticle

Abstract

Cardiovascular disease is a common cause of morbidity and mortality after solid organ transplantation, due to a combination of pre-existing cardiovascular risk factors and immunosuppressive drug toxicity. The prevalence of new-onset hypertension, dyslipidemia, diabetes mellitus, and metabolic syndrome was assessed after lung transplantation in a cohort of 67 patients (mean age: 48 ± 14 yr). The prevalence of hypertension increased from 19.4% to 70.1% at the three-yr follow-up visit (p 2 (p 

Original languageEnglish
JournalClinical Transplantation
Volume27
Issue number3
DOIs
Publication statusPublished - May 2013

Fingerprint

Lung Transplantation
Hypertension
Organ Transplantation
Immunosuppressive Agents
Dyslipidemias
Drug-Related Side Effects and Adverse Reactions
Diabetes Mellitus
Cardiovascular Diseases
Morbidity
Mortality

Keywords

  • Cardiovascular risk
  • Diabetes
  • Dyslipidemia
  • Hypertension
  • Immunosuppressive therapy
  • Metabolic syndrome
  • Solid organ transplantation

ASJC Scopus subject areas

  • Transplantation
  • Medicine(all)

Cite this

Early development of metabolic syndrome in patients subjected to lung transplantation. / Savioli, Gabriele; Surbone, Sara; Giovi, Ilaria; Salinaro, Francesco; Preti, Paola; Meloni, Federica; Oggionni, Tiberio; Perlini, Stefano.

In: Clinical Transplantation, Vol. 27, No. 3, 05.2013.

Research output: Contribution to journalArticle

@article{3ec9759d04464015950be23afef6e855,
title = "Early development of metabolic syndrome in patients subjected to lung transplantation",
abstract = "Cardiovascular disease is a common cause of morbidity and mortality after solid organ transplantation, due to a combination of pre-existing cardiovascular risk factors and immunosuppressive drug toxicity. The prevalence of new-onset hypertension, dyslipidemia, diabetes mellitus, and metabolic syndrome was assessed after lung transplantation in a cohort of 67 patients (mean age: 48 ± 14 yr). The prevalence of hypertension increased from 19.4{\%} to 70.1{\%} at the three-yr follow-up visit (p 2 (p ",
keywords = "Cardiovascular risk, Diabetes, Dyslipidemia, Hypertension, Immunosuppressive therapy, Metabolic syndrome, Solid organ transplantation",
author = "Gabriele Savioli and Sara Surbone and Ilaria Giovi and Francesco Salinaro and Paola Preti and Federica Meloni and Tiberio Oggionni and Stefano Perlini",
year = "2013",
month = "5",
doi = "10.1111/ctr.12098",
language = "English",
volume = "27",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Early development of metabolic syndrome in patients subjected to lung transplantation

AU - Savioli, Gabriele

AU - Surbone, Sara

AU - Giovi, Ilaria

AU - Salinaro, Francesco

AU - Preti, Paola

AU - Meloni, Federica

AU - Oggionni, Tiberio

AU - Perlini, Stefano

PY - 2013/5

Y1 - 2013/5

N2 - Cardiovascular disease is a common cause of morbidity and mortality after solid organ transplantation, due to a combination of pre-existing cardiovascular risk factors and immunosuppressive drug toxicity. The prevalence of new-onset hypertension, dyslipidemia, diabetes mellitus, and metabolic syndrome was assessed after lung transplantation in a cohort of 67 patients (mean age: 48 ± 14 yr). The prevalence of hypertension increased from 19.4% to 70.1% at the three-yr follow-up visit (p 2 (p 

AB - Cardiovascular disease is a common cause of morbidity and mortality after solid organ transplantation, due to a combination of pre-existing cardiovascular risk factors and immunosuppressive drug toxicity. The prevalence of new-onset hypertension, dyslipidemia, diabetes mellitus, and metabolic syndrome was assessed after lung transplantation in a cohort of 67 patients (mean age: 48 ± 14 yr). The prevalence of hypertension increased from 19.4% to 70.1% at the three-yr follow-up visit (p 2 (p 

KW - Cardiovascular risk

KW - Diabetes

KW - Dyslipidemia

KW - Hypertension

KW - Immunosuppressive therapy

KW - Metabolic syndrome

KW - Solid organ transplantation

UR - http://www.scopus.com/inward/record.url?scp=84878623468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878623468&partnerID=8YFLogxK

U2 - 10.1111/ctr.12098

DO - 10.1111/ctr.12098

M3 - Article

C2 - 23414418

AN - SCOPUS:84878623468

VL - 27

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 3

ER -